Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers

Although information about the efficacy and safety experience with caspofungin at 50 mg/m(2) daily is available for children and adolescents, the dosing regimen in infants and toddlers 3 to 24 months of age has yet to be established. We studied the pharmacokinetics and safety of caspofungin at 50 mg...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Neely, Michael, Jafri, Hasan S., Seibel, Nita, Knapp, Katherine, Adamson, Peter C., Bradshaw, Susan K., Strohmaier, Kim M., Sun, Peng, Bi, Sheng, Dockendorf, Marissa Fallon, Stone, Julie A., Kartsonis, Nicholas A.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2009
Teme:
Pharmacology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2663098/
https://ncbi.nlm.nih.gov/pubmed/19114680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01027-08
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items